Navigation Links
Stago to Discuss Direct Oral Anticoagulant Screening in Webinar for the Stago EdVantage Virtual University
Date:4/20/2017

As part of the Stago EdVantage Virtual University Virtual Event, this new webinar will explore challenging patient cases when screening for direct oral anticoagulant. When patients taking direct oral anticoagulants (DOACs) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of thrombosis recurrence.

By presenting information on DOAC interference in laboratory assays, institutional experience, and case studies, this webinar will address questions surrounding management of patients on DOAC therapy. Attendees of this webinar will learn from instances when presented with challenging cases, and be able to show how traditional and other laboratory measures can help guide safe, appropriate therapy.

Participants will also be able to gain a better understanding of how to identify the effects of DOACs, as well as describe common errors that are seen in practice when the effect of DOACs on common anticoagulation laboratory measures is not realized.

The speaker for this event will be Dr. Michael P Gulseth, PharmD, BCPS, FASHP. He is the program director for Anticoagulation Services at Sanford USD Medical Center & Clinical. He is also an associate professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.

Gulseth is a recognized expert in the area of anticoagulation administration and safety, having developed the 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy. He has authored numerous peer-reviewed publications in this area. In addition, he regularly serves as an editor for publications and presents at conferences of the American Society of Health-System Pharmacists (ASHP). He was elected as a fellow of the ASHP in 2011 and serves on the editorial advisory board of American Journal of Health-System Pharmacy (AJHP).

LabRoots will host the webinar April 26, 2017, commencing at 6:00 a.m. PDT. To learn more about the Stago EdVantage Virtual University Virtual Event, the continuing education credits offered, or to register for free, click here.

ABOUT DIAGNOSTICA STAGO, INC.
Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at http://www.stago-us.com.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14253391.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stago EdVantage Virtual University Virtual Event to Offer Webinar on Preanalytical Variables in Coagulation Testing
2. LGC Maine Standards Announces Release of VALIDATE® D-Dimer Calibration Verification / Linearity Test Kit for Stago STA-R® Evolution Analyzers
3. Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017
4. Agilent Technologies Discusses New Approach to Thyroid Hormone Analysis in Upcoming Webinar
5. Orexigen Therapeutics to Provide Business Update and Discuss Fourth Quarter and Year End 2016 Financial Results on March 28, 2017
6. Asymmetrex’s Head Will Lead Discussion on Supplying Private Stem Cell Clinics at the 6th Annual Clinical Trial Supply New England 2017 Conference in Boston
7. An upcoming segment of the Rob Lowe-Hosted "Informed" Public Television Series will Discuss Climate Change
8. SCIEX Sponsors a New Webinar Discussing the Routine Use of High Resolution Mass-Spec Analysis of Pesticides in Baby Food
9. Connect with DrugDev at the SCOPE Summit for Clinical Operations Executives for Engaging Customer-Led Panel Discussions and the Anticipated Reveal of DrugDev Spark™
10. Dr. Michael A. Pfaller of T2 Biosystems to Discuss the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship in New Webinar
11. Zymo Research Discusses Standardizing Workflows when Analyzing Networks of Exchanging Antibiotic Resistance in New Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , ... May 23, 2017 ... ... an unlimited source of human cardiovascular cells for research and the development ... makes it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to ...
(Date:5/23/2017)... ... May 23, 2017 , ... Vortex Biosciences , provider of circulating ... prostate circulating tumor cells using Vortex microfluidic technology ” in Nature Precision Oncology on ... Dr. Dino Di Carlo and Dr. Matthew Rettig at the University of California, Los ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge Semantics , the ... this year’s Bio-IT World Conference and Expo in Boston May 23-25 with ... solution. The Anzo Smart Data Lake is also a finalist for the Best ...
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer ... exhibiting in booth B2 at the Association for Pathology Informatics Annual Summit ... In addition to demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):